Literature DB >> 115789

Role of rabbit lysozyme in in vitro serum and plasma serum bactericidal reactions against Bacillus subtilis.

S F Carroll, R J Martinez.   

Abstract

The antibacterial activity of purified rabbit lysozyme was kinetically investigated at concentrations comparable to those in normal rabbit serum and plasma serum. The bactericidal capability, lysozyme content, and electrophoretic composition of "purified beta-lysin," fractionated from normal rabbit serum, were also examined. In contrast to the extensive antibacterial activity of dilute normal rabbit serum observed in vitro, rabbit lysozyme was only weakly bactericidal for Bacillus subtilis. Inhibition of lysozyme enzymatic and bactericidal activities in normal rabbit serum by antilysozyme immunoglobulin G slightly reduced the initial rate of killing. The addition of neutralizing antibody or histamine (another lysozyme inhibitor) to partially purified bactericidal serum fractions had no effect on killing kinetics. Increasing the ionic strength of reaction mixtures containing normal serum or partially purified bactericidal fractions to levels which completely inhibited lysozyme activity resulted in stimulation of their respective killing kinetics. The addition of inhibitors to normal rabbit plasma serum completely eliminated its bactericidal activity. With regard to the killing of B. subtilis by rabbit and human blood fractions, these analyses clearly demonstrated that (i) although lysozyme is not a significant antibacterial component of normal rabbit serum, it represents the principal factor in normal rabbit plasma serum; (ii) different primary bactericidal mechanisms which are not detectable by singlepoint analyses operate in the sera of different species; and (iii) purified beta-lysin isolated from normal rabbit serum by the classical procedure is a heterogenous mixture of components.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 115789      PMCID: PMC414520          DOI: 10.1128/iai.25.3.810-819.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  SEPARATION AND PURIFICATION OF BETA-LYSIN FROM NORMAL SERUM.

Authors:  D M DONALDSON; B ELLSWORTH; A MATHESON
Journal:  J Immunol       Date:  1964-06       Impact factor: 5.422

2.  The demonstration of lysozyme as a dominant tuberculostatic factor in extracts of granulomatous lungs.

Authors:  S OSHIMA; Q N MYRVIK; E LEAKE
Journal:  Br J Exp Pathol       Date:  1961-04

3.  Studies on serum bactericidal activity; interrelationships of heparin, citrate, protamine and xirradiation on serum and plasma bactericidal activity against Bacillus subtilis.

Authors:  D M DONALDSON; S MARCUS
Journal:  J Immunol       Date:  1958-10       Impact factor: 5.422

4.  Development of lysozyme-resistance in Micrococcus lysodiekticus and its association with an increased O-acetyl content of the cell wall.

Authors:  W BRUMFITT; A C WARDLAW; J T PARK
Journal:  Nature       Date:  1958-06-28       Impact factor: 49.962

5.  Studies on antibacterial factors in mammalian tissues and fluids. II. Cofactor requirements of a serum bactericidin for Bacillus subtilis.

Authors:  Q N MYRVIK; E SOTO-FIGUEROA; G NAFF; E HENELT
Journal:  J Immunol       Date:  1958-08       Impact factor: 5.422

6.  Studies on antibacterial factors in mammalian tissues and fluids. I. A serum bactericidin for Bacillus subtilis.

Authors:  Q N MYRVIK; R S WEISER
Journal:  J Immunol       Date:  1955-01       Impact factor: 5.422

7.  Studies on the mode of action of lysozyme on Mycobacteria.

Authors:  Q N MYRVIK; R S WEISER; M C KELLY
Journal:  Am Rev Tuberc       Date:  1953-10

8.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

9.  Comparative bactericidal activities of blood serum and plasma serum.

Authors:  J G HIRSCH
Journal:  J Exp Med       Date:  1960-07-01       Impact factor: 14.307

10.  The activation effect of calcium on a bactericidal substance for Bacillus subtilis in human serum.

Authors:  R F JACOX
Journal:  J Exp Med       Date:  1950-08       Impact factor: 14.307

View more
  3 in total

1.  Killing of Listeria monocytogens by conventional and germfree rat sera.

Authors:  C J Czuprynski; E Balish
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

2.  Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme.

Authors:  R J Martinez; S F Carroll
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

3.  Selective antibacterial properties of lysozyme for oral microorganisms.

Authors:  V J Iacono; B J MacKay; S DiRienzo; J J Pollock
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.